Cargando…

MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway

BACKGROUND: Sorafenib is a kinase inhibitor that is used as a first-line therapy in advanced hepatocellular carcinoma (HCC) patients. However, the existence of sorafenib resistance has limited its therapeutic effect. Through RNA sequencing, we demonstrated that miR-138-1-3p was downregulated in sora...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Tong-tong, Mou, Jie, Pan, Yao-jie, Huo, Fu-chun, Du, Wen-qi, Liang, Jia, Wang, Yang, Zhang, Lan-sheng, Pei, Dong-sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327419/ https://www.ncbi.nlm.nih.gov/pubmed/34340705 http://dx.doi.org/10.1186/s12929-021-00752-4

Ejemplares similares

MiR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5
por: Pan, Yao-Jie, et al.
Publicado: (2017)

MicroRNA roles in beta-catenin pathway
por: Huang, Kai, et al.
Publicado: (2010)

PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo
por: Zhang, Ying-Chun, et al.
Publicado: (2017)

MicroRNA-494 inhibits breast cancer progression by directly targeting PAK1
por: Zhan, Meng-Na, et al.
Publicado: (2017)

MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1
por: Yu, Chao, et al.
Publicado: (2015)

ANGPTL1 attenuates colorectal cancer metastasis by up-regulating microRNA-138
por: Chen, Haiyan, et al.
Publicado: (2017)

Sorafenib induces ferroptosis by promoting TRIM54-mediated FSP1 ubiquitination and degradation in hepatocellular carcinoma
por: Liu, Man-ru, et al.
Publicado: (2023)

MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1
por: Tian, Songyu, et al.
Publicado: (2016)

PAK1, PAK1Δ15, and PAK2: similarities, differences and mutual interactions
por: Grebeňová, Dana, et al.
Publicado: (2019)

PAK5‐stabilized Smuc confers renal cell carcinoma metastasis
por: Huo, Fu‐Chun, et al.
Publicado: (2021)

Hyperoside protects cardiomyocytes against hypoxia-induced injury via upregulation of microRNA-138
por: He, Siyi, et al.
Publicado: (2021)

MicroRNA-138 is a potential regulator of memory performance in humans
por: Schröder, Julia, et al.
Publicado: (2014)

Comprehensive analysis of circulating microRNAs as predictive biomarkers for sorafenib therapy outcome in hepatocellular carcinoma
por: Kohno, Tomoki, et al.
Publicado: (2020)

MicroRNA-138 Regulates Hypoxia-Induced Endothelial Cell Dysfunction By Targeting S100A1
por: Sen, Anagha, et al.
Publicado: (2013)

Suppressive effect of microRNA-138 on the proliferation and invasion of osteosarcoma cells via targeting SIRT1
por: Yuan, Zhenchao, et al.
Publicado: (2017)

MicroRNA-138-5p regulates the development of spinal cord injury by targeting SIRT1
por: Chen, Jinchuan, et al.
Publicado: (2020)

Regulation of ABCB1 activity by microRNA-200c and microRNA-203a in breast cancer cells: the quest for microRNAs’ involvement in cancer drug resistance
por: Armada, Ana, et al.
Publicado: (2019)

MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1
por: Sun, Kai-Xuan, et al.
Publicado: (2015)

Sorafenib-resistant hepatocellular carcinoma stratified by phosphorylated ERK activates PD-1 immune checkpoint
por: Chen, Jiang, et al.
Publicado: (2016)

Expansion of BCR/ABL1 (+) cells requires PAK2 but not PAK1
por: Edlinger, Leo, et al.
Publicado: (2017)

Egr2-dependent microRNA-138 is dispensable for peripheral nerve myelination
por: Lin, Hsin-Pin, et al.
Publicado: (2018)

MicroRNA-138 Increases Chemo-Sensitivity of Glioblastoma through Downregulation of Survivin
por: Yoo, Ji-Young, et al.
Publicado: (2021)

MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44
por: Yeh, Margaret, et al.
Publicado: (2021)

Sorafenib-Related Adverse Events in Predicting the Early Radiologic Responses of Hepatocellular Carcinoma
por: Lee, Shou-Wu, et al.
Publicado: (2019)

Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia
por: Corrêa, Stephany, et al.
Publicado: (2012)

MicroRNA-375 Targets ATG14 to Inhibit Autophagy and Sensitize Hepatocellular Carcinoma Cells to Sorafenib
por: Yang, Shuo, et al.
Publicado: (2020)

Correction: MicroRNA-138 Regulates Hypoxia-Induced Endothelial Cell Dysfunction By Targeting S100A1
por: Sen, Anagha, et al.
Publicado: (2013)

Correction: MicroRNA-138 Regulates Hypoxia-Induced Endothelial Cell Dysfunction By Targeting S100A1
por: Sen, Anagha, et al.
Publicado: (2014)

MicroRNA-138 negatively regulates the hypoxia-inducible factor 1α to suppress melanoma growth and metastasis
por: Qiu, Haijiang, et al.
Publicado: (2019)

MicroRNA-138-5p drives the progression of heart failure via inhibiting sirtuin 1 signaling
por: Sun, Shuai, et al.
Publicado: (2021)

[Retracted] Suppressive effect of microRNA‑138 on the proliferation and invasion of osteosarcoma cells via targeting SIRT1
por: Yuan, Zhenchao, et al.
Publicado: (2023)

Silencing of microRNA-138-5p promotes IL-1β-induced cartilage degradation in human chondrocytes by targeting FOXC1: miR-138 promotes cartilage degradation
por: Yuan, Y., et al.
Publicado: (2016)

Long non-coding RNA NCK1-AS1 promotes the tumorigenesis of glioma through sponging microRNA-138-2-3p and activating the TRIM24/Wnt/β-catenin axis
por: Huang, Lifa, et al.
Publicado: (2020)

Dysregulation of miR-138-5p/RPS6KA1-AP2M1 Is Associated With Poor Prognosis in AML
por: Yu, Dong-Hu, et al.
Publicado: (2021)

Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis
por: Mou, Tong, et al.
Publicado: (2017)

Glutamine synthetase mediates sorafenib sensitivity in β-catenin-active hepatocellular carcinoma cells
por: Sohn, Bo Hwa, et al.
Publicado: (2018)

Correction: Long non-coding RNA NCK1-AS1 promotes the tumorigenesis of glioma through sponging microRNA-138-2-3p and activating the TRIM24/Wnt/β-catenin axis
por: Huang, Lifa, et al.
Publicado: (2023)

Clinicopathological Significance of MicroRNA-20b Expression in Hepatocellular Carcinoma and Regulation of HIF-1α and VEGF Effect on Cell Biological Behaviour
por: Xue, Tong-min, et al.
Publicado: (2015)

Impact of mutant β-catenin on ABCB1 expression and therapy response in colon cancer cells
por: Stein, U, et al.
Publicado: (2012)

MicroRNA-138 Suppresses Neutrophil Gelatinase-Associated Lipocalin Expression and Inhibits Tumorigenicity
por: Lee, Ying Chu, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_47hlcvg38dec39c915v1955oa6